M2I Vision : Build in France a world-class industrial partner for custom synthesis and formulation of niche products in Healthcare (mainly generics), veterinary art, biological crop protection and organic electronics (Re)design synthetic routes and industrial processes for « hard to make » molecules (core capability) Propose to our clients a one stop shop from specification to regulatory clearance (DMF, MA) by teaming up with R&D and marketing teams The company operates a R&D center rance and a cGMP manufacturing plant. M2I holds a portfolio of proprietary DMFs and has already successfully applied its nonconventional retrosynthetic approach of active ingredients, using continuus processing, to solve important quality and stability issues on proprietary APIs. M2I also develops pheromones based solutions for crop protection and veterinary art. M2I works in close partnership with its clients to develop and supply high quality molecules in a cost efficient way.
| Website | http://www.m2i-group.fr |
| Employees | 133 (89 on RocketReach) |
| Founded | 2012 |
| Industry | Biotechnology Research |
| Keywords | Custom Synthesis, Contract Manufacturing, Pharmaceutical Manufacturing, Chemical Synthesis, Generic Drugs, Niche Products, Process Chemistry, Fine Chemicals, Veterinary Pharmaceuticals, Healthcare Ingredients, Active Pharmaceutical Ingredients, Crop Protection, Formulation, Api Manufacturing, Agricultural Chemicals, Organic Electronics, Drug Development, Regulatory Affairs, Biotechnology, Material Science |
| Competitors | Thermo Fisher Scientific, Biogen, MilliporeSigma, Bio-Techne, abcam, GenScript, New England Biolabs, PEPROTECH EC LTD, Biomatik Corporation, Molecular Dimensions +40 more (view full list) |
Looking for a particular M2I Life Sciences employee's phone or email?
Philippe Guerret is the Président directeur général groupe of M2I Life Sciences.
89 people are employed at M2I Life Sciences.